| Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ... ACS nano 4 (6), 3023-3032, 2010 | 312 | 2010 |
| Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications HA Santos, E Mäkilä, AJ Airaksinen, LM Bimbo, J Hirvonen Nanomedicine 9 (4), 535-554, 2014 | 144 | 2014 |
| Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution M Sarparanta, LM Bimbo, J Rytkönen, E Mäkilä, TJ Laaksonen, ... Molecular pharmaceutics 9 (3), 654-663, 2012 | 136 | 2012 |
| Multifunctional porous silicon nanoparticles for cancer theranostics CF Wang, MP Sarparanta, EM Mäkilä, MLK Hyvönen, PM Laakkonen, ... Biomaterials 48, 108-118, 2015 | 125 | 2015 |
| The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems MP Sarparanta, LM Bimbo, EM Mäkilä, JJ Salonen, PH Laaksonen, ... Biomaterials 33 (11), 3353-3362, 2012 | 113 | 2012 |
| Amine modification of thermally carbonized porous silicon with silane coupling chemistry E Mäkilä, LM Bimbo, M Kaasalainen, B Herranz, AJ Airaksinen, ... Langmuir 28 (39), 14045-14054, 2012 | 99 | 2012 |
| Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake CF Wang, EM Mäkilä, MH Kaasalainen, D Liu, MP Sarparanta, ... Biomaterials 35 (4), 1257-1266, 2014 | 97 | 2014 |
| Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S, S)-[18 F] FMeNER-D 2 N Seneca, B Gulyás, A Varrone, M Schou, A Airaksinen, J Tauscher, ... Psychopharmacology 188 (1), 119-127, 2006 | 91 | 2006 |
| 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography M Sarparanta, E Mäkilä, T Heikkilä, J Salonen, E Kukk, VP Lehto, ... Molecular pharmaceutics 8 (5), 1799-1806, 2011 | 78 | 2011 |
| Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [11C] vinpocetine B Gulyás, M Tóth, M Schain, A Airaksinen, Á Vas, K Kostulas, P Lindström, ... Journal of the neurological sciences 320 (1-2), 110-117, 2012 | 73 | 2012 |
| [18F] Flumazenil binding to central benzodiazepine receptor studies by PET:–Quantitative analysis and comparisons with [11C] flumazenil– I Odano, C Halldin, P Karlsson, A Varrone, AJ Airaksinen, RN Krasikova, ... Neuroimage 45 (3), 891-902, 2009 | 73 | 2009 |
| SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications C Nilsson, B Barrios-Lopez, A Kallinen, P Laurinmäki, SJ Butcher, M Raki, ... Biomaterials 34 (33), 8491-8503, 2013 | 67 | 2013 |
| Cellular interactions of surface modified nanoporous silicon particles LM Bimbo, M Sarparanta, E Mäkilä, T Laaksonen, P Laaksonen, ... Nanoscale 4 (10), 3184-3192, 2012 | 58 | 2012 |
| In vitro and in vivo assessment of heart-homing porous silicon nanoparticles MPA Ferreira, S Ranjan, AMR Correia, EM Mäkilä, SM Kinnunen, ... Biomaterials 94, 93-104, 2016 | 54 | 2016 |
| Adenovirus improves the efficacy of adoptive T-cell therapy by recruiting immune cells to and promoting their activity at the tumor S Tähtinen, S Grönberg-Vähä-Koskela, D Lumen, M Merisalo-Soikkeli, ... Cancer immunology research 3 (8), 915-925, 2015 | 53 | 2015 |
| Drug‐loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic Signaling MPA Ferreira, S Ranjan, S Kinnunen, A Correia, V Talman, E Mäkilä, ... Small 13 (33), 1701276, 2017 | 49 | 2017 |
| Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter T Hakkarainen, M Rajecki, M Sarparanta, M Tenhunen, AJ Airaksinen, ... Clinical Cancer Research 15 (17), 5396-5403, 2009 | 47 | 2009 |
| Pretargeting of internalizing trastuzumab and cetuximab with a 18 F-tetrazine tracer in xenograft models O Keinänen, K Fung, J Pourat, V Jallinoja, D Vivier, NVK Pillarsetty, ... EJNMMI research 7 (1), 1-12, 2017 | 39 | 2017 |
| Comparison of somatostatin receptor 2-targeting PET tracers in the detection of mouse atherosclerotic plaques P Rinne, S Hellberg, M Kiugel, J Virta, XG Li, M Käkelä, K Helariutta, ... Molecular imaging and biology 18 (1), 99-108, 2016 | 39 | 2016 |
| A new highly reactive and low lipophilicity fluorine-18 labeled tetrazine derivative for pretargeted PET imaging O Keinänen, XG Li, NK Chenna, D Lumen, J Ott, CFM Molthoff, ... ACS medicinal chemistry letters 7 (1), 62-66, 2016 | 38 | 2016 |
